Companies
Alphabet’s AI Bet Shakes Investors, but Fundamentals Stay Strong
Record spending plans spark market jitters even as Google delivers solid growth and AI momentum Alphabet (GOOG) shares slid sharply...
Bitcoin Slides After Treasury Pushback Signals No Government Backstop
Policy clarity, bearish warnings, and weak positioning deepen crypto’s latest sell-off Bitcoin extended its recent downturn on Wednesday, falling roughly...
Advanced Micro Devices Beats Earnings, but Shares Slide as AI Expectations Stay Sky-High
Strong data center growth and upbeat guidance fail to satisfy investors wary of valuation and competition Advanced Micro Devices (AMD)...
Intel Signals GPU Ambitions in Bid to Reclaim Data Center Relevance
New hires and foundry demand suggest a renewed push to challenge AI incumbents Intel (INTC) is making a decisive move...
Earnings Season Hits a Crucial Stretch as Tech Strength Meets Consumer Caution
Big Tech drives S&P 500 growth, while mixed results elsewhere reveal a divided economic landscape The fourth-quarter earnings season enters...
Bitcoin Slips as Traders Rotate Toward Metals and Defensive Bets
Derivatives data points to fragile sentiment despite signs of short-term stabilization Bitcoin resumed its downward trajectory as speculative traders shifted...
KULR Technology: The Market Trades Bitcoin — I’m Watching the Battery Business
The big picture Over the past year, KULR’s stock has behaved more like a Bitcoin proxy than a niche industrial...
Advanced Micro Devices Earnings Poised to Test the AI Trade’s Staying Power
AMD’s fourth-quarter report could clarify whether AI optimism still outweighs spending and supply concerns Advanced Micro Devices (AMD) is set...
Palantir Technologies Braces for High-Stakes Earnings as AI Momentum Collides With Valuation Debate
Wall Street expects explosive growth, but scrutiny around pricing and government reliance remains intense Palantir Technologies (PLTR) is set to...
Serina Therapeutics Advances Parkinson’s Program After Key FDA Green Light
IND clearance positions SER-252 for clinical progress in advanced Parkinson’s disease treatment Serina Therapeutics (SER) announced a significant regulatory milestone...
